CLINICAL_TRIALS
research
· 2024-07-31
Clinical Trial Update: Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)
Summary
The Galileo Project is a longitudinal study investigating genomic alterations and clonal evolution in ALK-positive non-small cell lung cancer and is currently r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: ALK Gene Mutation, NSCLC Stage IV | Status: RECRUITING